EMCDDA Director Alexis Goosdeel reported: ‘For your previous 25 decades, the EU Early Warning Program has contributed into a healthier and safer Europe by detecting and checking above 880 new drugs and assessing the threats of 37. Currently’s move by the European Fee to regulate two new stimulants, which might be in expanding supply, demonstrat